JAK inhibitors and alopecia areata

Affiliations

¹ Skin Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: doritg2000@gmail.com.
² Skin Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
³ Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA; Centre for Dermatology Research, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, UK.

Comment

Amos Gilhar et al. Lancet. 2019.

. 2019 Jan 26;393(10169):318-319.

doi: 10.1016/S0140-6736(18)32987-8.

¹ Skin Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: doritg2000@gmail.com.
² Skin Research Laboratory, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
³ Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA; Centre for Dermatology Research, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, UK.

No abstract available

Comment on

JAK inhibitors in dermatology: The promise of a new drug class.
Damsky W, King BA. Damsky W, et al. J Am Acad Dermatol. 2017 Apr;76(4):736-744. doi: 10.1016/j.jaad.2016.12.005. Epub 2017 Jan 28. J Am Acad Dermatol. 2017. PMID: 28139263 Free PMC article. Review.